Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
Ras activation has been correlated with malignant and metastatic cancer phenotypes and poor prognosis for cancer patients. In the preclinical setting, Ras activation by mutation or EGFR amplification results in increased clonogenic cell survival and decreased tumor growth delay following irradiation...
Những tác giả chính: | Cengel, K, Mckenna, W |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2005
|
Những quyển sách tương tự
-
Molecular radiosensitization of pancreatic carcinoma cell lines in vivo and in vitro
Bằng: Cengel, K, et al.
Được phát hành: (2004) -
The influence of Ras pathway signaling on tumor radiosensitivity.
Bằng: Kim, I, et al.
Được phát hành: (2004) -
Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
Bằng: Muschel, R, et al.
Được phát hành: (2001) -
The clinical implications of gemcitabine radiosensitization.
Bằng: Doyle, T, et al.
Được phát hành: (2001) -
Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
Bằng: Kim, I, et al.
Được phát hành: (2005)